Evidence map›Paper›PMID 40670533›Full record

ArticleScientific reports2025

The effect of copper on the antifungal activity of polyethyleneimines against quiescent conidia and germlings of Aspergillus nidulans.

Dimitris Tsiourvas, Zili Sideratou, Eleni Mavrogonatou, Dimitris Kletsas, Vicky Sophianopoulou, Spiros Gerostathis

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Dimitris TsiourvasInstitute of Nanoscience and Nanotechnology, National Centre for Scientific Research "Demokritos", Agia Paraskevi, 15341, Greece. d.tsiourvas@inn.demokritos.gr.
Zili SideratouInstitute of Nanoscience and Nanotechnology, National Centre for Scientific Research "Demokritos", Agia Paraskevi, 15341, Greece.
Eleni MavrogonatouLaboratory of Cell Proliferation and Ageing, Institute of Biosciences and Applications (IBA), National Centre for Scientific Research "Demokritos", Agia Paraskevi, 15341, Greece.
Dimitris KletsasLaboratory of Cell Proliferation and Ageing, Institute of Biosciences and Applications (IBA), National Centre for Scientific Research "Demokritos", Agia Paraskevi, 15341, Greece.
Vicky SophianopoulouMicrobial Molecular Genetics Laboratory, Institute of Biosciences and Applications (IBA), National Centre for Scientific Research "Demokritos", Agia Paraskevi, 15341, Greece. vicky@bio.demokritos.gr.
Spiros GerostathisMicrobial Molecular Genetics Laboratory, Institute of Biosciences and Applications (IBA), National Centre for Scientific Research "Demokritos", Agia Paraskevi, 15341, Greece.

Funding

National Recovery and Resilience Plan Greece 2.0, funded by the European Union - NextGenerationEU (Implementation body: HFRI, awarded to VS) 016779
6 · The paper itself

Abstract

The increase in the number of immunocompromised individuals combined with the severity of fungal infections in the general population has contributed to a significant increase in opportunistic fungal infections, which are often associated with high mortality rates. Although effective, existing antifungal drugs operate via a narrow range of mechanisms, leading to the rapid development of resistance and they primarily target growing host cells. Therefore, the need to develop next-generation antifungal agents that function via a broad range of mechanisms and/or target dormant/quiescent cells is highly important. In the present study, we investigated the characteristics and potential antifungal properties of a series of copper-chelated hyperbranched polyethyleneimines (PEI-Cu) with various molar ratios of Cu

Indexed as

Antifungal AgentsAspergillus nidulansCopperPolyethyleneimineSpores, FungalHumansMicrobial Sensitivity TestsAntifungal AgentsCopperPolyethyleneimine

Identifiers

PMID40670533
PMCPMC12267394

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.